These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33538421)

  • 1. Response to Braillon.
    Phipps M; Wattacheril J;
    Am J Gastroenterol; 2021 Mar; 116(3):617-618. PubMed ID: 33538421
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Braillon.
    Welzel TM; Graubard BI; Quraishi S; Zeuzem S; Davila JA; El-Serag HB; McGlynn KA
    Am J Gastroenterol; 2013 Dec; 108(12):1931. PubMed ID: 24300871
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to Braillon.
    Chang TS; Wu YC; Tsai YH; Huang YH
    Am J Gastroenterol; 2015 Nov; 110(11):1625-7. PubMed ID: 26618427
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to A. Braillon.
    Yuan Y; Li B; Qiu J
    J Clin Oncol; 2017 Jun; 35(18):2098-2099. PubMed ID: 28398849
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al.
    Brown KT; Do R; Gönen M; Covey AM; Getrajdman GI; Sofocleous CT; Jarnagin WR; D'Angelica MI; Allen PJ; Erinjeri JP; Brody LA; O'Neill GP; Johnson K; Garcia AR; Beattie CM; Zhao B; Solomon SB; Schwartz LH; DeMatteo RP; Abou-Alfa GK
    J Clin Oncol; 2017 Jan; 35(2):258-259. PubMed ID: 28056199
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatocellular carcinoma in the United States. Lessons from a population-based study in Medicare recipients.
    Varela M; Bruix J
    J Hepatol; 2006 Jan; 44(1):8-10. PubMed ID: 16297492
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: hepatocellular carcinoma in the absence of cirrhosis-a nightmare without solution.
    Ioannou GN
    Aliment Pharmacol Ther; 2019 Nov; 50(9):1062-1063. PubMed ID: 31625189
    [No Abstract]   [Full Text] [Related]  

  • 8. [Strategies for the management of hepatocellular carcinoma recommended by the American Association for the Study of Liver Diseases].
    Zhang HY; Luo SQ;
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):556-7. PubMed ID: 16867288
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for hepatocellular carcinoma: the rationale for the American Association for the Study of Liver Diseases recommendations.
    Sherman M; Bruix J; Porayko M; Tran T;
    Hepatology; 2012 Sep; 56(3):793-6. PubMed ID: 22689409
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening methods for hepatocellular carcinoma.
    Ezaki T
    AJR Am J Roentgenol; 1991 Apr; 156(4):869. PubMed ID: 1848390
    [No Abstract]   [Full Text] [Related]  

  • 11. Disparities in liver transplantation for localized hepatocellular carcinoma: race or socioeconomic class?
    Haque M; Zariat A
    Am J Gastroenterol; 2008 Jul; 103(7):1839-40; author reply 1840. PubMed ID: 18691200
    [No Abstract]   [Full Text] [Related]  

  • 12. Innovations in the Management of Hepatocellular Carcinoma.
    Rafiullah ; Ali A; Mohiuddin H; Zahid U; Abushahin L
    Am J Ther; 2018; 25(3):e362-e368. PubMed ID: 29561268
    [No Abstract]   [Full Text] [Related]  

  • 13. Liver transplantation and hepatocellular carcinoma biology: beginning of the end of the era of educated guesses.
    Vauthey JN; Ajani JA
    J Clin Oncol; 2003 Dec; 21(23):4265-7. PubMed ID: 14581443
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.
    Marrero JA; Kulik LM; Sirlin CB; Zhu AX; Finn RS; Abecassis MM; Roberts LR; Heimbach JK
    Hepatology; 2018 Aug; 68(2):723-750. PubMed ID: 29624699
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indication and current issues in liver transplantation for hepatocellular carcinoma].
    Kaihara S; Ogino S; Akioka S; Okamoto M; Yoshimura N
    Nihon Shokakibyo Gakkai Zasshi; 2004 Mar; 101(3):264-8. PubMed ID: 15065345
    [No Abstract]   [Full Text] [Related]  

  • 16. European cases of fibrolamellar hepatocellular carcinoma.
    Malondra AB; Picornell MF; Pons JT; Rovira JJ; Reines JB
    Ann Intern Med; 1989 Feb; 110(4):324. PubMed ID: 2536531
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to Dr. Ruffin.
    Borges AM; Swaroop VS; Desai PB
    Am J Gastroenterol; 1991 Jun; 86(6):789-90. PubMed ID: 1645499
    [No Abstract]   [Full Text] [Related]  

  • 18. Can We Move on From the Discussion of Direct Antiviral Agents and Risk of Hepatocellular Carcinoma Recurrence?
    Nault JC; Nahon P
    Gastroenterology; 2019 May; 156(6):1558-1560. PubMed ID: 30926345
    [No Abstract]   [Full Text] [Related]  

  • 19. Surveillance for hepatocellular carcinoma.
    Kelley MJ
    Ann Intern Med; 2011 Aug; 155(4):274; author reply 275. PubMed ID: 21844558
    [No Abstract]   [Full Text] [Related]  

  • 20. Surveillance of hepatocellular carcinoma: we must do better.
    Sherman M
    Am J Med; 2008 Feb; 121(2):89-90. PubMed ID: 18261492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.